BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30122176)

  • 1. Venous Thromboembolism in Special Populations: Preexisting Cardiopulmonary Disease, Cirrhosis, End-Stage Renal Disease, and Asplenia.
    Nguyen Q; Rivera-Lebron BN
    Clin Chest Med; 2018 Sep; 39(3):515-524. PubMed ID: 30122176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis.
    Ambrosino P; Tarantino L; Di Minno G; Paternoster M; Graziano V; Petitto M; Nasto A; Di Minno MN
    Thromb Haemost; 2017 Jan; 117(1):139-148. PubMed ID: 27761574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
    Yang Y; Zhang XZ; Ng HS; Fong JC; Lee LH
    Thromb Res; 2015 Sep; 136(3):548-51. PubMed ID: 26164397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic prophylaxis against venous thromboembolism in hospitalized patients with cirrhosis and associated coagulopathies.
    Koliscak L; Maynor L
    Am J Health Syst Pharm; 2012 Apr; 69(8):658-63. PubMed ID: 22472867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in laterality with emphasis on heterotaxy syndromes with asplenia and polysplenia: an autopsy case series at a single institution.
    Burton EC; Olson M; Rooper L
    Pediatr Dev Pathol; 2014; 17(4):250-64. PubMed ID: 24735181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.
    Salami A; Qureshi W; Kuriakose P; Moonka D; Yoshida A; Abouljoud M
    Transplant Proc; 2013; 45(1):315-9. PubMed ID: 23267811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature.
    Tufano A; Guida A; Di Minno MN; Prisco D; Cerbone AM; Di Minno G
    Semin Thromb Hemost; 2011 Apr; 37(3):267-74. PubMed ID: 21455860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients.
    Yang LS; Alukaidey S; Croucher K; Dowling D
    Intern Med J; 2018 Sep; 48(9):1056-1063. PubMed ID: 29468795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI).
    Königsbrügge O; Lorenz M; Auinger M; Schmaldienst S; Klauser-Braun R; Kletzmayr J; Grilz E; Posch F; Antlanger M; Pabinger I; Säemann M; Ay C
    Thromb Res; 2017 Oct; 158():59-64. PubMed ID: 28843824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous Thromboembolism in Brain Tumor Patients.
    Jeraq M; Cote DJ; Smith TR
    Adv Exp Med Biol; 2017; 906():215-228. PubMed ID: 27628002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in end-stage renal disease.
    Casserly LF; Reddy SM; Dember LM
    Am J Kidney Dis; 2000 Aug; 36(2):405-11. PubMed ID: 10922321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention, diagnosis and treatment of venous thromboembolism.
    Greenall R
    Nurs Older People; 2017 Jan; 29(1):21-25. PubMed ID: 28136021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease.
    Bogari H; Patanwala AE; Cosgrove R; Katz M
    Thromb Res; 2014 Dec; 134(6):1220-3. PubMed ID: 25294587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence.
    Rattazzi M; Villalta S; De Lucchi L; Sponchiado A; Galliazzo S; Faggin E; Pagliara V; Zilli C; Callegari E; Caberlotto L; Puato M; Pauletto P
    Thromb Res; 2017 Dec; 160():32-37. PubMed ID: 29091810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the management of venous thromboembolism.
    Bartholomew JR
    Cleve Clin J Med; 2017 Dec; 84(12 Suppl 3):39-46. PubMed ID: 29257737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of recurrent venous thromboembolism in patients with cancer: A review.
    Piran S; Schulman S
    Thromb Res; 2018 Apr; 164 Suppl 1():S172-S177. PubMed ID: 29703478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran.
    Fanola CL
    Vasc Health Risk Manag; 2015; 11():271-82. PubMed ID: 26064057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in cirrhosis.
    Yang ZJ; Costa KA; Novelli EM; Smith RE
    Clin Appl Thromb Hemost; 2014 Mar; 20(2):169-78. PubMed ID: 23076776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding.
    Intagliata NM; Henry ZH; Shah N; Lisman T; Caldwell SH; Northup PG
    Liver Int; 2014 Jan; 34(1):26-32. PubMed ID: 23758818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism, factor VIII and chronic kidney disease.
    Cheung KL; Bouchard BA; Cushman M
    Thromb Res; 2018 Oct; 170():10-19. PubMed ID: 30081388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.